What question did this study set out to answer?

The research aims to estimate effective doses of NOSO-502 in humans while analyzing its impact on pathogen clearance and resistance emergence.

March 26, 2026Journal of Antimicrobial Chemotherapy0 citationsOpen Access

The magnitude of the pharmacodynamic index for NOSO-502: pathogen clearance, emergence of resistance and human dose predictions

The research aims to estimate effective doses of NOSO-502 in humans while analyzing its impact on pathogen clearance and resistance emergence.
Utilized pharmacodynamic index (PDI) targets.
Estimated human pharmacokinetics of NOSO-502.
Analyzed dose-effect relationships.
Effectively estimated doses of NOSO-502 for human use.
Showed potential for significant pathogen clearance.
Identified implications for resistance emergence.

A combination of the use of PDI targets and prediction of human pharmacokinetics allowed effective doses of NOSO-502 in man to be estimated.

Demander à l'IA

Bookmark

View Full Paper

Berg et al. (Wed,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Demander à l'IA

Bookmark

View Full Paper